Viking Global Investors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-575,847
Closed -$30.6M 78
2019
Q3
$30.6M Sell
575,847
-1,220,928
-68% -$62.7M 0.16% 54
2019
Q2
$91.8M Sell
1,796,775
-422,299
-19% -$19.7M 0.41% 44
2019
Q1
$115M Buy
2,219,074
+462,724
+26% +$22.4M 0.66% 35
2018
Q4
$69.1M Sell
1,756,350
-47,754
-3% -$2.22M 0.39% 41
2018
Q3
$93M Buy
1,804,104
+31,323
+2% +$1.53M 0.51% 37
2018
Q2
$83.1M Sell
1,772,781
-152,767
-8% -$6.32M 0.48% 42
2018
Q1
$68.4M Buy
1,925,548
+367,036
+24% +$14.4M 0.41% 40
2017
Q4
$68M Buy
+1,558,512
New +$72.8M 0.42% 38

Other funds holding SYNH

Viking Global Investors's SYNH Position: Q4 2019 in Review

Viking Global Investors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2019, closing a stake of 575,847 shares — an estimated $30.6M sold.

Viking Global Investors first reported a position in SYNH in Q4 2017 and held it in 8 quarters. The position peaked at $115M in Q1 2019. 246 funds tracked by Wall St. Rank hold SYNH as of Q4 2019.

  • Viking Global Investors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2019 after selling out during the quarter.
  • Viking Global Investors sold 575,847 Syneos Health, Inc. Class A Common Stock shares in Q4 2019, an estimated $30.6M.
  • Viking Global Investors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 8 quarters.
  • Viking Global Investors's Syneos Health, Inc. Class A Common Stock position peaked at $115M in Q1 2019.
  • 246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2019.

Based on Viking Global Investors's 13F filing for Q4 2019, filed 13 Feb 2020.